ALEXANDRIA, Va., June 17 -- United States Patent no. 12,311,018, issued on May 27, was assigned to NantCell Inc. (Culver City, Calif.).
"Targeted neoepitope vectors and methods therefor" was invented by Kayvan Niazi (Culver City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods are presented that allow for selection of tumor neoepitopes that are then used to generate recombinant nucleic acids that encode one or more polytopes that are optimized for proper trafficking and processing. In preferred methods, the polytopes are encoded in a plasmid and/or a viral expression system for use as a therapeutic agent."
The patent was filed on Aug. 22, 2023, under Application No. 18/453,777.
*F...